Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch ...

Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

Endologix LLC announced 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select l ...

Artivion, Inc. announced that the FDA has approved the company’s AMDS hybrid prosthesis, an aortic arch remodeling device fo ...

Nectero Therapeutics announced the 2-year findings from a first-in-human (FIH) multicenter study evaluating treatment of small- to ...

StarMed America announced FDA 510(k) clearance for its radiofrequency ablation (RFA) devices for the treatment of thyroid ...

Reflow Medical, Inc. announced the enrollment of the first patient in the DEEPER CHALLENGE clinical trial, which is investigating e ...